Aptus Pharma IPO

Aptus Pharma Ltd is launching its SME IPO from September 23 to 25, 2025, with shares priced between ₹65 and ₹70 each. The Aptus Pharma IPO size is ₹13.02 crore through a fresh issue of approximately 18,60,000 shares. The minimum lot size is 2,000 shares, requiring an investment of about ₹1.3 lakh. The IPO will list on BSE SME, with allotment scheduled for September 26, 2025, refunds starting September 29, and listing expected on September 30, 2025.

Company Background

Aptus Pharma, established in 2010 and headquartered in Gujarat, markets a wide range of pharmaceutical products across multiple therapeutic areas. The company does not own manufacturing units but works with contract manufacturers to supply formulations in several categories, like anti-infectives, gastrointestinal, anti-allergic, nutritional supplements, and more. It serves diverse healthcare professionals, including general practitioners and specialists.

Operations And Product Range

Facility And Production

Aptus Pharma operates on a contract manufacturing model, sourcing products from seven reputed manufacturers. The company focuses on marketing, sales, and distribution while ensuring quality through strict vendor selection and control processes. Its supply chain is supported by strong distributor and stockist networks.

Brands And Market Presence

The Aptus Pharma IPO company’s brands are widely recognised in the healthcare segment due to their presence across multiple therapy areas. Its products reach customers mainly through pharma distributors and retailers across India, supported by a robust sales and marketing infrastructure, which includes a dedicated field force catering to healthcare professionals.

Revenue Channels

• • Marketing and sales of pharmaceutical formulations across diverse therapy categories.
• • Contract manufacturing partnerships with seven manufacturing units.
• • Distribution through a network of stockists and wholesalers across India.
• • Sales to hospitals, clinics, and pharmacies catering to various medical specialists.

Management And Shareholding

Promoters And Shareholding

The promoters of Aptus Pharma IPO hold significant stakes and are actively involved in the company’s strategic and operational decisions. The promoter group includes experienced professionals from the pharmaceutical domain who guide the company’s growth and compliance frameworks. The IPO will dilute the promoter’s stake, broadening the company’s equity base while ensuring promoter control remains.

Board Members

The board of directors comprises the promoter directors along with independent professionals who oversee audit, governance, risk management, and compliance matters. This mix ensures transparency, accountability, and strategic guidance necessary for a growing pharmaceutical marketer preparing for expanded visibility in public markets.